RxDoctor Payments Data

Daniel Eli Penn

Gastroenterology · Macon, GANPI 1528143377

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $57,200 of the $92,315 with a category attached, or 62.0%. AbbVie accounts for 85.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $46,466 and has fallen 99.5% since, to $223 in 2022. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,315in general payments, 2019–2025

Across 227 payments — averaging $406.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$79K
  • Endogastric Solutions, Inc$10K
  • Mauna Kea Technologies, Inc.$1K
  • Boston Scientific$534
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$460
  • Olympus America Inc.$175
  • plus $777 from 14 others

What the payments were for

  • Consulting fees$9,53810%
  • Speaking & faculty fees$57,20062%
  • Travel & lodging$21,06623%
  • Food & beverage$4,4675%
  • Education$440%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,315 in reported general payments places this provider in the 95th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia

Other gastroenterology in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →